Samsung Medison systems sit at an interesting spot in the ultrasound market. The brand carries the Samsung name and engineering investment, which means buyers get genuine R&D backing and a company with the resources to support its products long-term. The Medison division focuses specifically on ultrasound, which is narrower than GE or Philips' sprawling portfolios, and that focus shows in how consistently the systems perform in OB/GYN, women's imaging, and general radiology.
The HERA W10 is the flagship, designed specifically for women's health with 3D/4D capabilities and Crystal Vue rendering for detailed fetal anatomy. The RS85 serves as a premium general imaging and vascular platform with MV-Flow microvascular imaging. The HS60 covers mid-tier general imaging and is popular in outpatient and shared-service environments where multiple specialties share one room.
Samsung Medison systems tend to price between $80,000 and $180,000 for current models, which keeps most transactions within the application-only financing range. That means no tax returns, no financial statements, and a quick decision based on bank statements and the application itself. For OB/GYN groups and imaging centers that want to move quickly on a purchase, this is a real advantage.